Request Trial
illustrations-sentavio-shutterstock-com
ILLUSTRATIONS SENTAVIO / Shutterstock, Inc
6 June 2016AsiaOsamu Yamamoto

A hub of pharma innovation

The Japanese pharmaceutical market is the second largest in the world, accounting for around $100 billion of the total market share, according to the reports issued by the Japan Pharmaceutical Manufacturers Association. The local market has been dominated by brand drugs, with generics taking a lower share compared with other developed counties.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
IndiaMart v CDSCO: A test of intermediary liability
31 March 2026   The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.
Asia
Part I: Ozempic goes generic as Novo’s key patent expires
20 March 2026   As the patent protecting semaglutide—the drug that made Novo Nordisk one of Europe's most valuable companies—expires in ten countries, the pressure mounts for prices and market leaders alike.
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026   The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market.


Editor's picks

From the courtroom: Hikma v Amarin SCOTUS oral arguments
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026

Editor's picks

Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026
Europe
WIPR debuts Global In-House Elite 2026
26 March 2026
Biotechnology
mRNA litigation: Who’s winning, who’s filing, and what’s next
25 March 2026

More features

WATCH: Interview with Mythili Markowski, director at Regeneron
IP in the deal room: The risks that bite before, during and after closing
Teva can pursue monopoly claims over rival’s ‘exclusive pharmacy deal’
US judge allows rare patent defence in ‘world’s smallest heart pump’ suit
WATCH: John Ward, trademarks VP and associate GC of Moderna, at INTA
From the courtroom: Hikma v Amarin SCOTUS oral arguments
Moderna loses key mRNA patent in European vaccine fight
CureVac targets Moderna with 10-patent suit over Spikevax